ACLARIS THERAPEUTICS RECEIVES FAST TRACK DESIGNATION FOR MODZATINIB (ATI-2138) FOR MODERATE TO SEVERE LICHEN PLANUS (LP)

Reuters · 3d ago

Please log in to view news